DE60135972D1 - Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension - Google Patents
Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertensionInfo
- Publication number
- DE60135972D1 DE60135972D1 DE60135972T DE60135972T DE60135972D1 DE 60135972 D1 DE60135972 D1 DE 60135972D1 DE 60135972 T DE60135972 T DE 60135972T DE 60135972 T DE60135972 T DE 60135972T DE 60135972 D1 DE60135972 D1 DE 60135972D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- orthalmological
- compositions
- ocular hypertension
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17669500P | 2000-01-18 | 2000-01-18 | |
PCT/US2001/001623 WO2001052876A1 (en) | 2000-01-18 | 2001-01-17 | Ophthalmic compositions for treating ocular hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135972D1 true DE60135972D1 (de) | 2008-11-13 |
Family
ID=22645448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135972T Expired - Fee Related DE60135972D1 (de) | 2000-01-18 | 2001-01-17 | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension |
Country Status (8)
Country | Link |
---|---|
US (2) | US6545036B2 (de) |
EP (1) | EP1251862B1 (de) |
JP (1) | JP2003520245A (de) |
AT (1) | ATE409491T1 (de) |
AU (1) | AU771130B2 (de) |
CA (1) | CA2396319A1 (de) |
DE (1) | DE60135972D1 (de) |
WO (1) | WO2001052876A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
US7196082B2 (en) * | 2002-11-08 | 2007-03-27 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
CN100384827C (zh) * | 2002-11-08 | 2008-04-30 | 默克公司 | 用于治疗高眼压症的眼用组合物 |
CA2519899A1 (en) * | 2003-03-27 | 2004-10-14 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
BRPI0414102A (pt) * | 2003-09-04 | 2006-10-31 | Merck & Co Inc | composto, uso do mesmo, e, composição |
US20050250779A1 (en) * | 2004-05-04 | 2005-11-10 | Song Zhu | Pteridinone derivatives for treating ocular hypertension |
WO2007009001A1 (en) * | 2005-07-12 | 2007-01-18 | The Regents Of The University Of California | Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to alleviate eye disorders |
WO2008027340A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
US20090061009A1 (en) * | 2007-08-29 | 2009-03-05 | Joseph Schwarz | Composition and Method of Treatment of Bacterial Infections |
CA2795720A1 (en) * | 2010-04-12 | 2011-10-20 | R-Tech Ueno, Ltd. | Pharmaceutical composition for treating macular edema |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1518443A (en) * | 1976-02-19 | 1978-07-19 | Labaz | Indolizine derivatives and process for preparing the same |
DE3026402A1 (de) * | 1980-07-11 | 1982-02-04 | Syntex Corp., Palo Alto, Calif. | Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen |
US4416890A (en) | 1981-07-13 | 1983-11-22 | Merck & Co., Inc. | Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure |
US4442118A (en) * | 1981-07-23 | 1984-04-10 | Ayerst, Mckenna & Harrison, Inc. | Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid |
US4386098A (en) | 1981-11-03 | 1983-05-31 | Merck & Co., Inc. | 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure |
US4426388A (en) | 1982-04-02 | 1984-01-17 | Merck & Co., Inc. | 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure |
US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
US4668697A (en) | 1983-10-31 | 1987-05-26 | Merck & Co., Inc. | Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor |
US4863922A (en) | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
US4797413A (en) | 1986-05-14 | 1989-01-10 | Merck & Co., Inc. | Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use |
US4883819A (en) | 1986-07-31 | 1989-11-28 | The Trustees Of Columbia University In The City Of New York | Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma |
US4824857A (en) | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
DE3876050T2 (de) | 1987-09-18 | 1993-03-25 | R Tech Ueno Ltd | Okulare hypotensivagenzien. |
AU3693789A (en) | 1988-05-10 | 1989-11-29 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | New ophthalmic preparation for treating glaucoma |
CA2037923C (en) * | 1989-07-25 | 1996-08-06 | Akihiro Kawaguchi | Oxindole derivative |
US5081122A (en) * | 1990-03-05 | 1992-01-14 | Sterling Drug Inc. | Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof |
CA2036307C (en) * | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
US5153192A (en) | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
US5378703A (en) | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
US5175164A (en) * | 1991-06-05 | 1992-12-29 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted indole or dihydroindole |
US5292736A (en) * | 1993-02-26 | 1994-03-08 | Sterling Winthrop Inc. | Morpholinoalkylindenes as antiglaucoma agents |
CA2164733A1 (en) | 1993-06-08 | 1994-12-22 | Nino Sorgente | Methods and compositions for lowering intraocular pressure |
GB9420529D0 (en) * | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
US5484940A (en) * | 1994-11-28 | 1996-01-16 | Grant; Francine S. | Substituted 3-indolyl-5-pyrazolone compounds |
US5532237A (en) * | 1995-02-15 | 1996-07-02 | Merck Frosst Canada, Inc. | Indole derivatives with affinity for the cannabinoid receptor |
US5573758A (en) | 1995-04-28 | 1996-11-12 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
EP0801060A1 (de) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclische Beta-3 adrenergische Angonisten |
US5925342A (en) | 1996-11-13 | 1999-07-20 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
-
2001
- 2001-01-17 AU AU30963/01A patent/AU771130B2/en not_active Ceased
- 2001-01-17 DE DE60135972T patent/DE60135972D1/de not_active Expired - Fee Related
- 2001-01-17 US US09/764,738 patent/US6545036B2/en not_active Expired - Fee Related
- 2001-01-17 AT AT01903102T patent/ATE409491T1/de not_active IP Right Cessation
- 2001-01-17 CA CA002396319A patent/CA2396319A1/en not_active Abandoned
- 2001-01-17 EP EP01903102A patent/EP1251862B1/de not_active Expired - Lifetime
- 2001-01-17 JP JP2001552923A patent/JP2003520245A/ja not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001623 patent/WO2001052876A1/en active IP Right Grant
-
2003
- 2003-02-10 US US10/361,666 patent/US6914070B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3096301A (en) | 2001-07-31 |
CA2396319A1 (en) | 2001-07-26 |
WO2001052876A1 (en) | 2001-07-26 |
US6545036B2 (en) | 2003-04-08 |
US6914070B2 (en) | 2005-07-05 |
US20030153613A1 (en) | 2003-08-14 |
EP1251862A1 (de) | 2002-10-30 |
AU771130B2 (en) | 2004-03-11 |
EP1251862B1 (de) | 2008-10-01 |
US20010044460A1 (en) | 2001-11-22 |
ATE409491T1 (de) | 2008-10-15 |
JP2003520245A (ja) | 2003-07-02 |
EP1251862A4 (de) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005002520A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2007108968A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
NO20052751L (no) | Oftalmisk preparat for behandling av okulaer hypertensjon. | |
WO2003047513A3 (en) | Method for treating ocular hypertension | |
ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
ATE254461T1 (de) | Behandlung von augenschmerzen | |
BR0210205A (pt) | Antiinfecciosos | |
ATE426413T1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
WO2005020917A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
BRPI0406879A (pt) | Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos | |
DK1056454T3 (da) | Anvendelse af makrolidforbindelser til behandling af glaukom | |
WO2004043354A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
DE60135972D1 (de) | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension | |
DE60334905D1 (de) | 1,5-disubstituierte pyrrolid-2-on-derivate zur verwendung als ep4 rezeptor agonisten zur behandlung von augenkrankheiten wie z.b. glaukom | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
WO2003105781A3 (en) | OPHTHALMIC COMPOSITIONS FOR TREATING EYE HYPERTENSION | |
WO2006020003A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2007146136A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
BR0017158A (pt) | Agonistas de 5ht2 para controlar a iop e tratar o glaucoma | |
BR0314419A (pt) | Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o | |
NO20061505L (no) | Optalmiske preparater for behandling av okular hyperensjon | |
BR0316775A (pt) | Novos análogos de benzopirano e seu uso para o tratamento de glaucoma | |
WO2003105724A3 (en) | NOVEL MAXI K CHANNEL BLOCKERS, METHODS OF USE AND MANUFACTURING METHODS THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |